版本:
中国

BRIEF-Acasti Pharma says CaPre Phase 3 on track to start in late 2017

March 30 Acasti Pharma Inc:

* Acasti Pharma provides update on capre phase 3 development program

* Confirms phase 3 program is on track to start late 2017

* Acasti Pharma - FDA's feedback supports co's plan to conduct two studies instead of one large study, potentially shortening time to NDA submission Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐